Bank of New York Mellon’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-408,416
| Closed | -$7.33M | – | 4487 |
|
|
2017
Q4 | $7.33M | Sell |
408,416
-5,888
| -1% | -$72.5K | ﹤0.01% | 2155 |
|
|
2017
Q3 | $4.89M | Buy |
414,304
+47,639
| +13% | +$534K | ﹤0.01% | 2349 |
|
|
2017
Q2 | $3.85M | Sell |
366,665
-1,026
| -0.3% | -$10.5K | ﹤0.01% | 2455 |
|
|
2017
Q1 | $4.04M | Buy |
367,691
+190,292
| +107% | +$2.21M | ﹤0.01% | 2430 |
|
|
2016
Q4 | $2.4M | Buy |
177,399
+46,565
| +36% | +$650K | ﹤0.01% | 2742 |
|
|
2016
Q3 | $1.61M | Buy |
130,834
+6,368
| +5% | +$75K | ﹤0.01% | 2897 |
|
|
2016
Q2 | $1.36M | Sell |
124,466
-21,335
| -15% | -$239K | ﹤0.01% | 2944 |
|
|
2016
Q1 | $1.59M | Sell |
145,801
-228,321
| -61% | -$2.89M | ﹤0.01% | 2790 |
|
|
2015
Q4 | $6.47M | Buy |
374,122
+49,119
| +15% | +$881K | ﹤0.01% | 2076 |
|
|
2015
Q3 | $6.46M | Sell |
325,003
-14,151
| -4% | -$324K | ﹤0.01% | 2091 |
|
|
2015
Q2 | $5.57M | Sell |
339,154
-4,956
| -1% | -$85.9K | ﹤0.01% | 2285 |
|
|
2015
Q1 | $5.35M | Buy |
344,110
+254,662
| +285% | +$3.95M | ﹤0.01% | 2285 |
|
|
2014
Q4 | $1.28M | Sell |
89,448
-13,998
| -14% | -$148K | ﹤0.01% | 3151 |
|
|
2014
Q3 | $672K | Buy |
103,446
+1,137
| +1% | +$7.55K | ﹤0.01% | 3512 |
|
|
2014
Q2 | $706K | Buy |
102,309
+888
| +0.9% | +$6.28K | ﹤0.01% | 3498 |
|
|
2014
Q1 | $725K | Buy |
101,421
+7,693
| +8% | +$65.8K | ﹤0.01% | 3434 |
|
|
2013
Q4 | $881K | Buy |
93,728
+28,090
| +43% | +$200K | ﹤0.01% | 3363 |
|
|
2013
Q3 | $410K | Sell |
65,638
-22,928
| -26% | -$143K | ﹤0.01% | 3586 |
|
|
2013
Q2 | $583K | Buy |
+88,566
| New | +$703K | ﹤0.01% | 3437 |
|
Other funds holding SCMP
Bank of New York Mellon's SCMP Position: Q1 2018 in Review
Bank of New York Mellon sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 408,416 shares — an estimated $7.33M sold.
Bank of New York Mellon first reported a position in SCMP in Q2 2013 and held it in 19 quarters. The position peaked at $7.33M in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.
- Bank of New York Mellon reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
- Bank of New York Mellon sold 408,416 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $7.33M.
- Bank of New York Mellon first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2013 and held it in 19 quarters.
- Bank of New York Mellon's Sucampo Pharmaceuticals, Inc. position peaked at $7.33M in Q4 2017.
- 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.
Based on Bank of New York Mellon's 13F filing for Q1 2018, filed 15 May 2018.